| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/09/2009 | CA2710380A1 Treatment of fibrotic conditions |
| 07/09/2009 | CA2710375A1 Treatment of orthopedic conditions |
| 07/09/2009 | CA2710232A1 Treatment of abnormal or excessive scars |
| 07/09/2009 | CA2710227A1 Treatment of surgical adhesions |
| 07/09/2009 | CA2710223A1 Treatment of surgical adhesions |
| 07/09/2009 | CA2710013A1 Immunomodulatory agents and methods of use |
| 07/08/2009 | EP2077326A1 Novel nucleic acid |
| 07/08/2009 | EP2077277A1 Use of mammalian cytokine; related reagents |
| 07/08/2009 | EP2076587A2 Isolation, expansion and uses of tumor stem cells |
| 07/08/2009 | EP1962889B1 Immunogenic polypeptide composed of tumor antigen-derived optimized cryptic peptides, and uses thereof |
| 07/08/2009 | EP1776126A4 Methods of using regenerative cells in the treatment of stroke and related diseases and disorders |
| 07/08/2009 | EP1539933A4 Methods of organ regeneration |
| 07/08/2009 | EP1383927B1 New polynucleotides and polypeptides of the erythropoietin gene |
| 07/08/2009 | EP1371730B1 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 07/08/2009 | EP1114172B1 Transfer method for specific cellular localisation of nucleic acids |
| 07/08/2009 | CN101474413A Use of DRR1 gene in preparing anti-tumor medicament |
| 07/08/2009 | CN100510087C Modular transfection system |
| 07/07/2009 | US7557200 Superior molecular vaccine based on self-replicating RNA, suicidal DNA or naked DNA vector, that links antigen with polypeptide that promotes antigen presentation |
| 07/07/2009 | US7557197 Human soluble neuropilin-1 primary polyadenylation signal and uses thereof |
| 07/07/2009 | US7557187 Polypeptide; an amino acid sequence of the family of tumour-suppressing genes related to the gene for the p53 protein; isolated nucleic acid sequences coding for the proteins |
| 07/07/2009 | US7556965 Structural protein of adeno-associated virus with modified antigenicity, its production and its use |
| 07/07/2009 | US7556963 Nucleotide sequences coding caspase for use in identifying modulators for treatment of allergies, cancer, and pathogenic infection |
| 07/07/2009 | US7556957 Attenuated virus-like particle for use as gene transfer tool in treatment and prevention of metabolic disorders; tissue target therapy |
| 07/07/2009 | US7556920 Polypeptide that forms part of a ubiquitin-ligase complex involved in targeting proteins by ubiquitination for degradation by the proteasome; cancer (breast and prostate carcinoma), immune/inflammatory disease and neurological disease |
| 07/07/2009 | US7556827 Implantable active ingredient depot comprising matrix of glyceryl-monooleate and at least one modifier molecule comprising 1,2-distearoyl-glycerophosphatidyl-ethanolamin-methyl-polyethylene glycol wherein matrix provides controlled release of active ingredient |
| 07/07/2009 | US7556825 Method for promoting hair growth |
| 07/07/2009 | US7556809 Utilizing vascular epithelial growth factor (VEGFR1) polypeptides, fragments and/or encoding oligonucleotides |
| 07/07/2009 | US7556805 Compositions for treatment of melanoma and method of using same |
| 07/07/2009 | US7556803 Using kappa-myeloma antigen specific immunoglobulins to target and destroy tumor cells; immunotherapy |
| 07/07/2009 | CA2304255C Hepatitis b virus polypeptides |
| 07/07/2009 | CA2201161C Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof |
| 07/07/2009 | CA2167692C Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors |
| 07/02/2009 | WO2009082744A2 Prognosis and interference-mediated treatment of breast cancer |
| 07/02/2009 | WO2009082593A2 Dendritic cell vaccine compositions and uses of same |
| 07/02/2009 | WO2009082448A2 Modified oligonucleotides for the treatment of hepatitis c infection |
| 07/02/2009 | WO2009081287A2 Polysaccharide nanoparticles |
| 07/02/2009 | WO2009081154A1 Targeted delivery of macromolecules |
| 07/02/2009 | WO2009081065A2 Method of preparing a material formed from branched molecules comprising associative groups |
| 07/02/2009 | WO2009080899A2 Products and methods affecting cell and tissue growth |
| 07/02/2009 | WO2009080898A2 Products and methods for preventing tumour growth |
| 07/02/2009 | WO2009080299A1 Sm-protein based secretion engineering |
| 07/02/2009 | WO2009079834A1 An anti-hcv vaccine and preparation methods and uses thereof |
| 07/02/2009 | WO2009079790A1 Polypeptide-nucleic acid conjugates and uses thereof |
| 07/02/2009 | WO2009079768A1 Methods of inhibiting tumor growth using ttk antagonists |
| 07/02/2009 | WO2009058766A3 Methods of regulating the expression of mir-34a and p18ink4c |
| 07/02/2009 | WO2008142198A3 A method for inhibiting or stimulating angiogenesis in an individual |
| 07/02/2009 | WO2007141005A8 Use of glutamyl aminopeptidase (enpep) as a therapeutic or diagnostic target |
| 07/02/2009 | US20090171077 Delivery of nucleic acid-like compounds |
| 07/02/2009 | US20090170799 Chimeric oligonucleotide for use in diagnosis and treatment of tissue destruction, necrosis and inflammatory diseases |
| 07/02/2009 | US20090170792 Peptide ligands |
| 07/02/2009 | US20090170763 Modified gherlin peptides |
| 07/02/2009 | US20090170748 Plasmid mediated supplementation for treating chronically ill subjects |
| 07/02/2009 | US20090170197 Nucleic Acid-Mediated Treatment of Diseases or Conditions Related to Levels of Vascular Endothelial Growth Factor Receptor (VEGF-R) |
| 07/02/2009 | US20090170193 Stem cells |
| 07/02/2009 | US20090170191 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
| 07/02/2009 | US20090170146 Novel Carboxylesterase Nucleic Acid Molecules, Proteins and Uses Thereof |
| 07/02/2009 | US20090170099 Use of Regulatory Sequences for Specific, Transient Expression in Neuronal Determined Cells |
| 07/02/2009 | US20090170098 Antibodies to cell-cycle regulatory protein p16, and uses related thereto |
| 07/02/2009 | US20090170095 Mnk KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM |
| 07/02/2009 | US20090169612 Systemic Immune Activation Method Using Nucleic Acid-Lipid Complexes |
| 07/02/2009 | US20090169579 Modified vaccinia Ankara virus avriant |
| 07/02/2009 | US20090169574 Heteroclitic analogs and related methods |
| 07/02/2009 | US20090169564 Stimulus Inducible Protein Kinase Complex and Methods of Use Therefor |
| 07/02/2009 | US20090169563 Administering monoclonal antibody or an antigen-binding portion thereof that specifically binds to and activates human CD40; Gene therapy; nucleic acid coding immunoglobulins; anticancer agents |
| 07/02/2009 | US20090169543 Method for regulating immune function in primates using the Foxp3 protein |
| 07/02/2009 | US20090169526 Bmp-6 estrogen responsive element and methods of use thereof |
| 07/02/2009 | US20090169517 Compositions and Methods for Tumor-Targeted Delivery of Effector Molecules |
| 07/02/2009 | US20090169506 USE OF gp130 ACTIVATORS IN DIABETIC NEUROPATHY |
| 07/02/2009 | US20090169476 Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer |
| 07/02/2009 | CA2709645A1 Sm-protein based secretion engineering |
| 07/02/2009 | CA2709635A1 Polypeptide-nucleic acid conjugates and uses thereof |
| 07/02/2009 | CA2708686A1 Methods of inhibiting tumor growth using ttk antagonists |
| 07/01/2009 | EP2075582A2 Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers |
| 07/01/2009 | EP2075346A2 Gene products differentially expressed in cancerous breast cells and their methods of use |
| 07/01/2009 | EP2075340A2 Gene modulation by RB2/p 130 expression |
| 07/01/2009 | EP2075334A1 EG-VEGF nucleic acids and polypeptides and methods of use |
| 07/01/2009 | EP2075255A1 Human FGF-23 gene and gene expression products |
| 07/01/2009 | EP2075002A2 Use of myoblasts in the manufacture of a medicament for treating stress urinary incontinence |
| 07/01/2009 | EP2074136A2 Enzymes for the treatment of lignocellulosics, nucleic acids encoding them and methods for making and using them |
| 07/01/2009 | EP2073849A2 Methods and compositions for gene therapy |
| 07/01/2009 | EP2073837A2 Recombinant modified vaccinia ankara encoding a her-2 antigen for use in treating cancer |
| 07/01/2009 | EP1708575A4 Improved modalities for the treatment of degenerative diseases of the retina |
| 07/01/2009 | EP1565208B1 The use of cytochrome p450 enzyme cyp2wi as a drug traget for cancer therapy |
| 07/01/2009 | EP1552018B1 Methods and compositions relating to gene silencing |
| 07/01/2009 | EP1377165B1 Tsg101-gag interaction and use thereof |
| 07/01/2009 | EP1261704B1 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
| 07/01/2009 | EP1124846B1 Nucleotide and protein sequences of nogo genes and methods based thereon |
| 07/01/2009 | EP1104310B1 Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response |
| 07/01/2009 | EP1080216B1 Retroviral delivery system |
| 07/01/2009 | EP0915973B1 Gene involved in cadasil, method of diagnosis and therapeutic application |
| 07/01/2009 | EP0871748B1 Delivery of biologically active polypeptides |
| 07/01/2009 | CN101469329A Compositions and methods for increasing bone mineralization |
| 07/01/2009 | CN100506980C Composition comprising the polyprotein ns3/ns4 and the polypeptide ns5b of hcv, expression vectors including the corresponding nucleic sequence and their therapeutic use |
| 07/01/2009 | CN100506845C IFNAR2 mutants, their production and use |
| 07/01/2009 | CN100506844C Novel peptides |
| 07/01/2009 | CN100506841C Method and carrier complexes for delivering molecules to cells |
| 07/01/2009 | CN100506285C Application of expression TRAIL protein colon bacillus for preparing medicine to treat tumor |
| 07/01/2009 | CN100506284C Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
| 06/30/2009 | USRE40811 Administering anti-VLA-4 antibody (or anti-VCAM-1 antibody) which blocks binding VLA-4 antigen on surface of CD34 cells to VCAM-1 or fibronectin, thereby increasing number of CD34+ cells in peripheral blood; colony stimulating factors |
| 06/30/2009 | US7553933 Human p51 genes and gene products thereof |